Clinical bottom line:
• Insulin and dextrose infusion should form the first line of therapy in hyperkalaemia of the premature infant. [Grade A]
• Oral and rectal ion exchange resins should be avoided as they are ineffective and associated with significant and potentially life threatening complications. [Grade A]
• No substantial data show the superiority of salbutamol over insulin/dextrose for premature infants [Grade D]
• Exchange transfusion may be used as a last resort therapy. [Grade D]
- intraventricular haemorrhage
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.